These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23636177)

  • 1. Incidence of antibodies to protamine sulfate/heparin complexes incardiac surgery patients and impact on platelet activation and clinical outcome.
    Pouplard C; Leroux D; Rollin J; Amiral J; May MA; Gruel Y
    Thromb Haemost; 2013 Jun; 109(6):1141-7. PubMed ID: 23636177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological features of antibodies to protamine inducing thrombocytopenia and thrombosis.
    Panzer S; Schiferer A; Steinlechner B; Drouet L; Amiral J
    Clin Chem Lab Med; 2015 Feb; 53(2):249-55. PubMed ID: 25153412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass.
    Lee GM; Welsby IJ; Phillips-Bute B; Ortel TL; Arepally GM
    Blood; 2013 Apr; 121(15):2828-35. PubMed ID: 23422751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
    Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
    Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
    Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
    Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.
    Zöllner H; Jouni R; Panzer S; Khadour A; Janzen L; Wesche J; Ten Berg M; Schellong S; Heinken A; Greinacher A; Bakchoul T
    J Thromb Haemost; 2017 Jan; 15(1):176-184. PubMed ID: 27759896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine (heparin)-induced thrombocytopenia: a review of the serological and clinical features associated with anti-protamine/heparin antibodies.
    Bakchoul T; Jouni R; Warkentin TE
    J Thromb Haemost; 2016 Sep; 14(9):1685-95. PubMed ID: 27378603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.
    Alexy T; Tucker S; Boyle S; Rowe VL; Weaver FA; Liebman HA
    J Vasc Surg; 2008 Aug; 48(2):377-81. PubMed ID: 18515040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.
    Satoh T; Tanaka Y; Okazaki Y; Kaburaki J; Ikeda Y; Kuwana M
    Rheumatology (Oxford); 2012 Sep; 51(9):1721-8. PubMed ID: 22718864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets.
    Jouni R; Zöllner H; Khadour A; Wesche J; Grotevendt A; Brandt S; Delcea M; Krauel K; Schwertz H; Sachs UJ; Greinacher A; Bakchoul T
    Thromb Haemost; 2016 Jan; 115(2):324-32. PubMed ID: 26423467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
    Pouplard C; Amiral J; Borg JY; Vissac AM; Delahousse B; Gruel Y
    Br J Haematol; 1997 Nov; 99(2):273-80. PubMed ID: 9375738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.